We present a comprehensive overview of the stereoscopic Intel RealSense RGBD imaging systems. We discuss these systems' mode-of-operation, functional behavior and include models of their expected performance, shortcomings, and limitations. We provide information about the systems' optical characteristics, their correlation algorithms, and how these properties can affect different applications, including 3D reconstruction and gesture recognition. Our discussion covers the Intel RealSense R200 and the Intel RealSense D400 (formally RS400).
▪ Abstract Rapid advances in the field of photorefractive polymers and composites have in the brief time since their inception in 1991 led to the development of high-performance materials with refractive index modulations approaching 0.01, dif-fraction efficiencies close to 100%, and net two-beam coupling gain coefficients exceeding 200 cm−1 in samples typically 100 μm thick. This paper reviews the current state of research, from the most successful synthetic strategies to produce polymeric photorefractive materials, to their emerging uses in applications. Two-beam coupling and four-wave mixing measurement techniques are presented and their importance in the characterization of the photorefractive properties of new materials is explained. The physics of the photorefractive effect in polymers is discussed with emphasis placed on the differences compared with the traditional inorganic photorefractive crystals. In particular, the orientational enhancement mechanism, which is believed to be responsible for the high performance of most of the low-glass-transition-temperature systems, is discussed in detail.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.